Evidence map›Paper›PMID 21854302›Full record

ReviewExpert opinion on biological therapy2011

Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing.

Alexander R Badiavas, Evangelos V Badiavas

Registry-linked trialAbstract readReview
In one paragraph

Review in Expert opinion on biological therapy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02169362 (Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02169362 phase1unknown statusnot on this mapstarted 2014, after this paper: background citation

Phase I, Double-Blind, Randomized, Controlled Study to Demonstrate the Safety of Applying Autologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™) to Acute Deep Partial Thickness Thermal Injuries

TypeinterventionalSponsorArteriocyte, Inc.Ran2014 to 2018Enrolled36ConditionsAcute Deep Partial Thickness Thermal BurnsArmsAutologous Platelet Rich Plasma (PRP) Gel (Magellan® Bio-Bandage™)
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mesenchymal Stem Cells Application in Wound Tissue Healing in Old Animals.Stem cells and cloning : advances and applications · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexander R BadiavasJefferson Medical College, PA, USA.
Evangelos V Badiavas

Funding

Bone Marrow Stem Cells and the Microenvironment of Chronic WoundsR01AG027874 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BADIAVAS, EVANGELOS VAN · 2007 to 2011
$1.6M
NIA NIH HHS R01 AG027874NIA NIH HHS R01AG027874
6 · The paper itself

Abstract

introductionIt is becoming increasingly evident that select adult stem cells have the capacity to participate in repair and regeneration of damaged and/or diseased tissues. Mesenchymal stem cells have been among the most studied adult stem cells for the treatment of a variety of conditions, including wound healing. AREAS COVERED: Mesenchymal stem cell features potentially beneficial to cutaneous wound healing applications are reviewed. EXPERT OPINION: Given their potential for in vitro expansion and immune modulatory effects, both autologous and allogeneic mesenchymal stem cells appear to be well suited as wound healing therapies. Allogeneic mesenchymal stem cells derived from young healthy donors could have particular advantage over autologous sources where age and systemic disease can be significant factors.

Indexed as

Mesenchymal Stem Cell TransplantationWound HealingAdult Stem CellsAnimalsHumansTransplantation, HomologousTreatment Outcome

Identifiers

PMID21854302
PMCPMC3188697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.